Two Sigma Investments LP Purchases Shares of 42,479 Electromed, Inc. (NYSE:ELMD)

Two Sigma Investments LP purchased a new position in shares of Electromed, Inc. (NYSE:ELMD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 42,479 shares of the company's stock, valued at approximately $1,255,000. Two Sigma Investments LP owned 0.50% of Electromed as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Arrowstreet Capital Limited Partnership boosted its position in shares of Electromed by 261.0% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 114,579 shares of the company's stock worth $3,386,000 after buying an additional 82,839 shares during the period. Northern Trust Corp boosted its position in shares of Electromed by 14.1% during the fourth quarter. Northern Trust Corp now owns 65,350 shares of the company's stock worth $1,931,000 after buying an additional 8,086 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Electromed during the fourth quarter worth $1,760,000. Susquehanna International Group LLP boosted its position in shares of Electromed by 121.8% during the fourth quarter. Susquehanna International Group LLP now owns 56,726 shares of the company's stock worth $1,676,000 after buying an additional 31,148 shares during the period. Finally, Navellier & Associates Inc. boosted its position in shares of Electromed by 228.5% during the fourth quarter. Navellier & Associates Inc. now owns 56,368 shares of the company's stock worth $1,666,000 after buying an additional 39,208 shares during the period. 40.82% of the stock is currently owned by hedge funds and other institutional investors.

Electromed Trading Up 0.8%

NYSE:ELMD traded up $0.17 during midday trading on Friday, reaching $20.95. The company had a trading volume of 49,762 shares, compared to its average volume of 72,999. The firm has a market capitalization of $175.69 million, a price-to-earnings ratio of 27.93 and a beta of 0.40. The stock's fifty day simple moving average is $21.97 and its 200-day simple moving average is $26.72. Electromed, Inc. has a 12-month low of $13.74 and a 12-month high of $35.56.

Electromed announced that its board has authorized a share buyback plan on Monday, March 10th that allows the company to repurchase $5.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 2.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board of directors believes its shares are undervalued.

Analyst Ratings Changes

Several research analysts have recently commented on the company. B. Riley upgraded Electromed to a "strong-buy" rating in a research report on Thursday, May 15th. Wall Street Zen lowered Electromed from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 8th.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.